Table 1.
MRSA | Non MRSA | Total | ||
(n = 20) | (n = 326) | (n = 346) | P-value | |
Age (yr, mean ± SD) | 52.4 ± 21.9 | 56.9 ± 20.3 | 56.7 ± 20.4 | .330 |
Gender M N (%) | 18 (90) | 202 (62) | 220 (63.6) | .011 |
HLOS (d, mean ± SD) | 77.5 ± 81.9 | 47.5 ± 49.7 | 49.3 ± 52.4 | .013 |
Co-morbidities | 17 | 294 | 311 | .44 |
DM | 6 (30.3) | 128 (39.3) | 134 (38.7) | .409 |
HTN | 9 (45) | 169 (51.8) | 178 (51.4) | .552 |
Cardiac diseases | 9 (45) | 94 (28.8) | 103 (29.8) | .125 |
Brain diseases | 8 (40) | 109 (33.4) | 117 (33.8) | .547 |
Lung diseases | 2 (10) | 54 (16.6) | 56 (16.2) | .539 |
Kidney diseases | 2 (10) | 32 (9.8) | 34 (9.8) | .979 |
Malignancies | 3 (15) | 45 (13.8) | 48 (13.9) | .881 |
Mortality (%) | 11 (55.0%) | 262 (80.4%) | 273 (78.9%) | .007 |
Super infections (%) | 13 (65) | 295 (90.5) | 308 (89) | .003 |